DOI: https://doi.org/10.22141/2224-0721.14.1.2018.127095

Characteristics of specific immunological indicators in patients with postoperative relapse of Graves’ disease

Yu.V. Buldigina, S.L. Shlyakhtich, G.M. Terekhova

Abstract


Background. Activity of autoimmune processes had a leading role in the development of relapse of hyperthyroidism. Level of thyroid-stimulating hormone (TSH) receptor antibodies is a basic factor that predetermines the relapse and can be used as a criterion to evaluate its development. A research aim was to study the structural and functional state of the thyroid gland, levels of thyroid peroxidase antibodies and TSH receptor antibodies in patients with postoperative relapse of Graves’ disease during antithyroid therapy. Mate­rials and methods. The group of patients consisted of 25 wo­men aged 23 to 73 years (an average of 53.56 ± 2.31 years). The period from the first surgical treatment to the development of relapse of thyrotoxicosis ranged from 1 to 29 years and avera­ged 13.33 ± 1.66 years. Results. It was found that the le­vels of TSH receptor antibodies, which are the main factors in the pathogenesis of Graves’ disease, are not decreased on the background of drug treatment that indicates a lack of perspective of conservative therapy for the post-operative relapse of this disease. Conclusions. When the state of medication compensation for thyrotoxicosis is achieved, it is recommended to conduct the therapy with I131 or surgical treatment of the relapse of Graves’ disease.


Keywords


Graves’ disease; thyroid-stimulating hormone receptor antibodies; postoperative relapse

References


Cirocchi R, Trastulli S, Randolph J, et al. Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults. Cochrane Database Syst Rev. 2015;(8):CD010370. doi: 10.1002/14651858.CD010370.pub2.

Stathopoulos P, Gangidi S, Kotrotsos G, Cunliffe D. Graves' disease: a review of surgical indications, management, and complications in a cohort of 59 patients. Int J Oral Maxillofac Surg. 2015 Jun;44(6):713-7. doi: 10.1016/j.ijom.2015.02.007.

Wilhelm SM, McHenry CR. Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States. World J Surg. 2010 Jun;34(6):1261-4. doi: 10.1007/s00268-009-0337-3.

Pankiv VI, ed. Syndrom tyreotoksykozu v klinichnij praktyci [Syndrome of thyrotoxicosis in clinical practice]. LAP LAMBERT Academic Publishing; 2017. 110 p. (in Ukrainian).

Girgis CM, Champion BL, Wall JR. Current concepts in graves’ disease. Ther Adv Endocrinol Metab. 2011 Jun;2(3):135-44. doi: 10.1177/2042018811408488.

Bartalena L, Burch HB, Burman KD, Kahaly GJ. A 2013 European survey of clinical practice patterns in the management of Graves’ disease. Clin Endocrinol (Oxf). 2016 Jan;84(1):115-20. doi: 10.1111/cen.12688.

Burch HB, Cooper DS. Management of Graves disease: А review. JAMA. 2015 Dec 15;314(23):2544-54. doi: 10.1001/jama.2015.16535.

Villagelin D, Romaldini JH, Santos RB, Milkos ABBP, Ward LS. Outcomes in relapsed Graves’ disease patients following radioiodine or prolonged low dose of methimazole treatment. Thyroid. 2015 Dec;25(12):1282-90. doi: 10.1089/thy.2015.0195.

Daukšienė D, Daukša A, Mickuvienė N. Independent pretreatment predictors of Graves’ disease outcome. Medicina (Kaunas) 2013;49(10):427-434. PMID: 24709784.

Stathopoulos P, Gangidi S, Kotrotsos G, Cunliffe D. Graves’ disease: a review of surgical indications, management, and complications in a cohort of 59 patients. Int J Oral Maxillofac Surg. 2015 Jun;44(6):713-7. doi: 10.1016/j.ijom.2015.02.007.

Annerbo M, Stalberg P, Hellman P. Management of Grave′s diseases is improved by total thyroidectomy. World J Surg. 2012 Aug;36(8):1943-6. doi: 10.1007/s00268-012-1617-x.

Sung TY, Lee YM, Yoon YH, KW, Hong SJ. Long-term effects of surgery in Grave′s diseases: 20 years experience in a single institution. Int J Endocrinol. 2015;2015:542641. doi: 10.1155/2015/542641.

Gendeleka GF. Atypical Forms of Autoimmune Thyroid Disease Course as a Manifestation of Autoimmune Overlap Syndrome. Mìžnarodnij endokrinologìčnij žurnal. 2014;3(59):103-107. (in Russian)

Opoku-Boateng A, Wang TS, Sosa IA. Thyroidectomy in patients with Graves’ disease. In: Graves' disease (Chapter). 2015. 99-113 pp.

Bojic T, Paunovic I, Diklic A, et al. Total thyroidectomy as a method of choice in the treatment of Graves' disease – analysis of 1432 patients. BMC Surg. 2015 Apr 9;15:39. doi: 10.1186/s12893-015-0023-3.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта